Abdallah El Sabbagh
Mayo Clinic
Internal medicineRadiologySurgeryCardiologyHemodynamicsPsychological interventionMitral valve replacementAortic valve replacementArteryCardiac catheterizationMitral valveAcute coronary syndromeCoronary artery diseaseStenosisValve replacementRegurgitation (circulation)Percutaneous coronary interventionPercutaneousMitral annular calcificationIn patientTranscatheter aorticConventional PCIMyocardial infarctionMedicine
90Publications
13H-index
621Citations
Publications 89
Newest
#1Uri Landes (Rabin Medical Center)H-Index: 13
#2Guy Witberg (Rabin Medical Center)H-Index: 11
Last. John G. Webb (Vancouver General Hospital)H-Index: 15
view all 36 authors...
Importance Transcatheter aortic valve replacement (TAVR) failure is often managed by an urgent implantation of a supplementary valve during the procedure (2-valve TAVR [2V-TAVR]). Little is known about the factors associated with or sequelae of 2V-TAVR. Objective To examine the incidence, causes, and outcomes of 2V-TAVR. Design, Setting, and Participants A retrospective cohort study was performed using data from an international registry of 21 298 TAVR procedures performed from January 1, 2014, ...
Source
Source
Source
Source
Source
Source
#1Andrew N. RosenbaumH-Index: 10
#2C. Charles JainH-Index: 4
Last. Atta BehfarH-Index: 37
view all 6 authors...
In patients with advanced heart failure (HF), temporary mechanical circulator support (TMCS) is used to improve hemodynamics, via left ventricular unloading, and end-organ function as a bridge to definitive therapy. While listed for cardiac transplantation, use of TMCS may be prolonged, preventing adequate mobility. Here, we describe the technique for placement of a percutaneous axillary intra-aortic balloon pump (IABP) using single-site arterial access to facilitate ambulation and subsequent sa...
Source
#1Mohammed Al-Hijji (Mayo Clinic)H-Index: 12
#2Stephanie El-hajj (Mayo Clinic)H-Index: 1
Last. Mayra Guerrero (Mayo Clinic)H-Index: 24
view all 8 authors...
BACKGROUND Surgical intervention in patients with native mitral disease due to severe mitral annular calcification (MAC) carries significant risk. Transcatheter mitral valve replacement (TMVR) using balloon-expandable aortic transcatheter heart valve (THV) in MAC had emerged as alternative treatment. OBJECTIVES We aim to study the temporal change in clinical outcomes of the procedure at a single center. METHODS We retrospectively studied 23 patients who underwent TMVR in MAC at Mayo Clinic from ...
Source
#1Keniel F. Pierre (Mayo Clinic)H-Index: 1
#2Demilade Adedinsewo (Mayo Clinic)H-Index: 7
Last. Abdallah El Sabbagh (Mayo Clinic)H-Index: 13
view all 10 authors...
BACKGROUND Change in left atrial pressure (LAP) has been shown to be associated with symptom improvement post-MitraClip; however, the association between acute procedural changes in transmitral diastolic mean gradient (MG) compared to LAP and symptom improvement is not well established. METHODS 164 consecutive patients undergoing MitraClip at Mayo Clinic between June 2014 and May 2018 were included. Preclip and postclip MG and LAP were recorded. Baseline demographics, clinical, and echocardiogra...
Source
#1Charlene L. Rohm (Mayo Clinic)
#2Salman Farhat (Mayo Clinic)H-Index: 2
Last. Abdallah El Sabbagh (Mayo Clinic)H-Index: 13
view all 7 authors...
BACKGROUND Transcatheter aortic valve-in-valve replacement (ViV) has been widely accepted as a less invasive alternative to treat failed aortic surgical or transcatheter bioprosthetic valves. Angulated aortas present an additional challenge, particularly when using self-expanding transcatheter heart valves (SE-THV). METHODS Two patients with failed surgical bioprosthetic aortic valves and one patient with a failed transcatheter bioprosthetic aortic valve underwent transcatheter aortic ViV using ...
Source